Palatin Technologies (PTN) News Today → FW: 234x Gain (From Weiss Ratings) (Ad) Free PTN Stock Alerts $2.12 +0.07 (+3.41%) (As of 01:56 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBuy Rating Endorsed for Palatin Technologies Amidst Promising Obesity Treatment Advancementsmarkets.businessinsider.com - May 3 at 1:22 AMPalatin spikes as FDA clears mid-stage trial for weight loss therapymsn.com - May 2 at 5:30 PMPalatin gets FDA OK to test weight loss therapy with Eli Lilly’s tirzepatideseekingalpha.com - May 2 at 5:30 PMPalatin: FDA Clears IND Application For Bremelanotide Phase 2 Studymarkets.businessinsider.com - May 2 at 12:29 PMPalatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with Tirzepatide (GLP-1) for the Treatment of Obesityprnewswire.com - May 2 at 7:30 AMPalatin to Host Virtual KOL Event "Beyond GLPs: The Multiple Roles for Novel Melanocortin Receptor 4 Agonists in Treating Obesity and Weight Loss Maintenance" on May 8, 2024prnewswire.com - April 30 at 7:30 AMPalatin Technologies (NYSEAMERICAN:PTN) Shares Cross Above Two Hundred Day Moving Average of $0.00americanbankingnews.com - April 27 at 3:20 AMPalatin Technologies And 2 Other Stocks Under $3 Insiders Are Buyingmsn.com - April 12 at 10:36 AMPalatin Technologies, Inc. (NYSEAMERICAN:PTN) Director Purchases $12,720.00 in Stockinsidertrades.com - April 12 at 6:56 AMPalatin Technologies Shares Rise 27% After Positive Trial Results for PL9643marketwatch.com - April 8 at 1:18 PMPalatin Technologies Eyes Growing $6B Dry Eye Disease Market With Late-Stage Study Datafinance.yahoo.com - April 8 at 1:18 PMGalectin Therapeutics, Titan Pharmaceuticals, Outset Medical among healthcare moversmsn.com - April 8 at 10:21 AMPalatin stock jumps 16% on positive Phase 3 data for eye drugmsn.com - April 8 at 10:12 AMPalatin Says Topline Results From The Phase 3 MELODY-1 Study Of PL9643 In Dry Eye Disease Positivemarkets.businessinsider.com - April 8 at 8:18 AMPalatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024finance.yahoo.com - April 8 at 8:18 AMPalatin Technologies, Inc. (NYSEAMERICAN:PTN) Director Robert K. Deveer, Jr. Sells 11,700 Sharesinsidertrades.com - March 17 at 8:52 AMPTN Apr 2024 2.500 putfinance.yahoo.com - March 15 at 10:53 PMPTN Apr 2024 7.500 callfinance.yahoo.com - March 15 at 10:53 PMPalatin files to sell 1.92M shares of common stock for holdersmsn.com - March 14 at 7:20 PMMaintained Buy Rating on Palatin Technologies Amid Promising Clinical Results and Future Prospectsmarkets.businessinsider.com - February 29 at 3:20 PMAnalysts Offer Insights on Healthcare Companies: Immunocore Holdings (IMCR), Palatin Technologies (PTN) and G1 Therapeutics (GTHX)markets.businessinsider.com - February 28 at 5:21 PMAnalysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN) and Opko Health (OPK)markets.businessinsider.com - February 28 at 2:50 PMPalatin Technologies' Disappointing Data From Dry Eye Disease Study, Stock Plummetsmsn.com - February 28 at 12:20 PMPalatin Technologies, Inc.: Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)finanznachrichten.de - February 28 at 9:49 AMPalatin Technologies Shares Tumble Premarket on Dry-Eye Study Resultsmarketwatch.com - February 28 at 9:49 AMPalatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)finance.yahoo.com - February 28 at 8:42 AMPalatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)prnewswire.com - February 28 at 7:30 AMPalatin Technologies, Inc. (PTN)finance.yahoo.com - February 21 at 1:05 PMBuy Rating Affirmed on Palatin Technologies for Promising Pipeline and Strategic Market Positioningmarkets.businessinsider.com - February 16 at 10:14 PMBuy Rating Affirmed for Palatin Technologies Amid Promising Clinical Trials and Robust Financial Positionmarkets.businessinsider.com - February 16 at 10:14 PMPalatin Technologies, Inc. (AMEX:PTN) Q2 2024 Earnings Call Transcriptfinance.yahoo.com - February 16 at 10:46 AMPalatin Techs Stock (AMEX:PTN), Quotes and News Summarybenzinga.com - February 16 at 2:58 AMQ2 2024 Palatin Technologies Inc Earnings Callfinance.yahoo.com - February 16 at 2:58 AMOptimistic Buy Rating for Palatin Technologies Backed by Strong Clinical Pipeline and Strategic Initiativesmarkets.businessinsider.com - February 15 at 6:21 PMPalatin Technologies, Inc.: Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Updatefinanznachrichten.de - February 15 at 8:20 AMPalatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Updatefinance.yahoo.com - February 15 at 8:20 AMThe 3 Best Penny Stocks to Buy in February 2024investorplace.com - February 15 at 7:49 AMPalatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Updateprnewswire.com - February 15 at 7:30 AMPalatin Technologies, Inc. (NYSEAMERICAN:PTN) Short Interest Updatemarketbeat.com - February 14 at 6:14 AMPalatin Technologies (NYSEAMERICAN:PTN) Share Price Passes Above Two Hundred Day Moving Average of $0.00marketbeat.com - February 14 at 3:39 AMPalatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024finance.yahoo.com - February 9 at 8:05 AMPalatin Technologies (NYSEAMERICAN:PTN) Stock Crosses Above 200-Day Moving Average of $0.00marketbeat.com - February 6 at 3:04 AMPalatin Technologies Shares Jump After Database Lock of Dry Eye Disease Drug Studymarketwatch.com - February 5 at 2:59 PMPalatin Technologies, Inc.: Palatin Announces Database Lock for PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)finanznachrichten.de - February 5 at 9:56 AMPalatin Announces Database Lock for PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)finance.yahoo.com - February 5 at 7:48 AMPalatin Technologies Strikes Deal for $9.2M Capital Boostmsn.com - February 2 at 1:35 PMPalatin Announces Closing of $10 Million Registered Direct Offeringfinance.yahoo.com - February 1 at 6:10 PMPalatin Technologies Shares Drop 11% After Direct Offeringmarketwatch.com - January 30 at 12:00 PMPalatin Technologies Prices Offering Of $10 Mln Of Shares; Stock Down Over 4% In Pre-Marketmarkets.businessinsider.com - January 30 at 12:00 PMStrength Seen in Repligen (RGEN): Can Its 4.3% Jump Turn into More Strength?finance.yahoo.com - January 29 at 9:35 AM Get Palatin Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for PTN and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13. See his shocking evidence in this new report PTN Media Mentions By Week PTN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PTN News Sentiment▼0.250.37▲Average Medical News Sentiment PTN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PTN Articles This Week▼82▲PTN Articles Average Week Get Palatin Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for PTN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SPRB News LEXX News APRE News ACST News FBRX News SLGL News DARE News NRXP News QLI News DRRX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:PTN) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersThe AI stock to buy right nowStockEarningsUrgent Nvidia WarningAltimetryCould Your Accounts Be Frozen?Allegiance GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBill Gates is all about this tiny $2 stockTimothy Sykes$5,000 Gold?Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palatin Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
